These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7438694)

  • 1. Factors influencing nortriptyline steady-state kinetics: plasma and saliva levels.
    Kragh-Sørensen P; Larsen NE
    Clin Pharmacol Ther; 1980 Dec; 28(6):796-803. PubMed ID: 7438694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of serum nortriptyline and 10-hydroxy-nortriptyline measurements in the depressed elderly: a multicenter pharmacokinetic and pharmacodynamic study.
    Kin NM; Klitgaard N; Nair NP; Amin M; Kragh-Sorensen P; Schwariz G; Ahmed SK; Holm P; Katona C; Stage K
    Neuropsychopharmacology; 1996 Jul; 15(1):1-6. PubMed ID: 8797186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma 10-hydroxynortriptyline in elderly depressed patients.
    Young RC; Alexopoulos GS; Shamoian CA; Manley MW; Dhar AK; Kutt H
    Clin Pharmacol Ther; 1984 Apr; 35(4):540-4. PubMed ID: 6705454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial monitoring and achievement of steady state nortriptyline plasma levels in depressed children and adolescents: preliminary data.
    Geller B; Cooper TB; Chestnut EC
    J Clin Psychopharmacol; 1985 Aug; 5(4):213-6. PubMed ID: 4019809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of therapeutic effects in amitriptyline treatment--1. Plasma drug levels.
    Franke L; Schewe HJ; Uebelhack R; Müller-Oerlinghausen B
    Pharmacopsychiatry; 2003 Jul; 36(4):134-42. PubMed ID: 12905099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Child and adolescent nortriptyline single dose kinetics predict steady state plasma levels and suggested dose: preliminary data.
    Geller B; Cooper TB; Chestnut EC; Anker JA; Price DT; Yates E
    J Clin Psychopharmacol; 1985 Jun; 5(3):154-8. PubMed ID: 3998205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF and plasma levels of nortriptyline and its 10-hydroxy metabolite.
    Nordin C; Bertilsson L; Siwers B
    Br J Clin Pharmacol; 1985 Oct; 20(4):411-3. PubMed ID: 4074608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of individual dosage of nortriptyline in depressed elderly outpatients.
    Schneider LS; Cooper TB; Staples FR; Sloane RB
    J Clin Psychopharmacol; 1987 Oct; 7(5):311-4. PubMed ID: 3680600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of free nortriptyline levels to therapeutic response.
    Perry PJ; Browne JL; Alexander B; Pfohl BM; Dunner FJ; Sherman AD; Tsuang MT
    Acta Psychiatr Scand; 1985 Aug; 72(2):120-5. PubMed ID: 4050504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sampling time, dosage schedule, and nortriptyline plasma levels.
    Ziegler VE; Knesevich JW; Wylie LT; Biggs JT
    Arch Gen Psychiatry; 1977 May; 34(5):613-5. PubMed ID: 871235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of therapeutic drug monitoring data to document kinetic drug interactions: an example with amitriptyline and nortriptyline.
    Jerling M; Bertilsson L; Sjöqvist F
    Ther Drug Monit; 1994 Feb; 16(1):1-12. PubMed ID: 7909176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady state pharmacokinetics of nortriptyline in the frail elderly.
    Katz IR; Simpson GM; Jethanandani V; Cooper T; Muhly C
    Neuropsychopharmacology; 1989 Sep; 2(3):229-36. PubMed ID: 2789662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: significance of concurrent medication and the sparteine oxidation phenotype.
    Gram LF; Brøsen K; Kragh-Sørensen P; Christensen P
    Ther Drug Monit; 1989 Sep; 11(5):508-14. PubMed ID: 2815225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships among nortriptyline, 10-OH(E)nortriptyline, and 10-OH(Z)nortriptyline steady-state plasma levels and nortriptyline dosage.
    Lukey BJ; Jones DR; Wright JH; Hurst HE
    Ther Drug Monit; 1989; 11(3):221-7. PubMed ID: 2728080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of nortriptyline in man after single and multiple oral doses: the predictability of steady-state plasma concentrations from single-dose plasma-level data.
    Alexanderson B
    Eur J Clin Pharmacol; 1972 Mar; 4(2):82-91. PubMed ID: 4655685
    [No Abstract]   [Full Text] [Related]  

  • 16. Nortriptyline capacity-limited metabolism: a case report.
    Browne JL; Perry PJ; Taylor JW; Sieleni BA; Kronfol Z
    J Clin Psychopharmacol; 1984 Dec; 4(6):322-5. PubMed ID: 6511999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High plasma nortriptyline levels in the treatment of depression. I.
    Montgomery S; Braithwaite R; Dawling S; McAuley R
    Clin Pharmacol Ther; 1978 Mar; 23(3):309-14. PubMed ID: 627137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma binding variations of amitriptyline and nortriptyline.
    Pike E; Skuterud B
    Clin Pharmacol Ther; 1982 Aug; 32(2):228-34. PubMed ID: 7094510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of single dose kinetics of imipramine, nortriptyline and antipyrine in man.
    Gram LF; Andreasen PB; Overo KF; Christiansen J
    Psychopharmacology (Berl); 1976 Oct; 50(1):21-7. PubMed ID: 827758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nortriptyline metabolism in chronic renal failure: metabolite elimination.
    Dawling S; Lynn K; Rosser R; Braithwaite R
    Clin Pharmacol Ther; 1982 Sep; 32(3):322-9. PubMed ID: 7105623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.